Accessibility Menu
 
Shionogi & logo

Shionogi &

(OTC) SGIOF

Current Price$22.63
Market Cap$17.03B
Since IPO (2003)+366%
5 Year+22%
1 Year+33%
1 Month-13%

Shionogi & Financials at a Glance

Market Cap

$17.03B

Revenue (TTM)

$464.38B

Net Income (TTM)

$194.62B

EPS (TTM)

$1.52

P/E Ratio

13.13

Dividend

$0.43

Beta (Volatility)

0.25 (Low)

Price

$22.63

Volume

256

Open

$22.63

Previous Close

$19.81

Daily Range

$22.63 - $22.63

52-Week Range

$14.25 - $26.00

SGIOF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Shionogi &

Industry

Pharmaceuticals

Employees

4,955

CEO

Akira Kato, PhD; Isao Teshirogi, PhD

Headquarters

Osaka, 541-0045, JP

SGIOF Financials

Key Financial Metrics (TTM)

Gross Margin

84%

Operating Margin

35%

Net Income Margin

42%

Return on Equity

14%

Return on Capital

10%

Return on Assets

11%

Earnings Yield

7.62%

Dividend Yield

0.02%

Payout Ratio

28.96%

Stock Overview

Market Cap

$17.03B

Shares Outstanding

850.98M

Volume

256

Short Interest

0.00%

Avg. Volume

358.902

Financials (TTM)

Gross Profit

$374.44B

Operating Income

$156.60B

EBITDA

$230.71B

Operating Cash Flow

$195.46B

Capital Expenditure

$52.10B

Free Cash Flow

$143.36B

Cash & ST Invst.

$644.82B

Total Debt

$21.88B

Shionogi & Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

$147.85B

+19332.0%

Gross Profit

$122.17B

+18615.4%

Gross Margin

82.63%

N/A

Market Cap

$17.03B

N/A

Market Cap/Employee

$3.44M

N/A

Employees

4,955

N/A

Net Income

$74.75B

+23095.4%

EBITDA

$100.62B

+23087.2%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Net Cash

$175.06B

-38.0%

Accounts Receivable

$193.19B

+34.2%

Inventory

$98.98B

+45.7%

Long Term Debt

$35.81B

+84.3%

Short Term Debt

$4.91B

-32.2%

Return on Assets

11.28%

N/A

Return on Invested Capital

10.37%

N/A

Free Cash Flow

$30.47B

+12204.7%

Operating Cash Flow

$32.06B

+12256.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BIOVFSwedish Orphan Biovitrum AB (publ)
$39.87+0.00%
SBMFFSino Biopharmaceutical Limited
$0.76-8.60%
SONVYSonova Holding AG
$44.32-1.31%
SONVFSonova Holding AG
$219.00-0.45%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.25-0.06%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.34-0.02%
SKYQSky Quarry
$6.89+0.38%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.40+0.02%

Questions About SGIOF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.